New means of payment for cancer therapies (Q10095): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Label in wikidata changed) |
(Created claim: summary (P836): The project is subject to new currency, complex, with increased reactivity in an internal environment marked by the presence of weakly bound, potentially reactive anon-ligands of strong conjugated acids. The solution will result in a completely new group of Pt (IV) of treatments for cancer therapies with increased toxicity and selective treatment for cancer cells, little toxicity to healthy cells, and high bioavailability from GIT, allowing ora...) |
||
| Property / summary | |||
The project is subject to new currency, complex, with increased reactivity in an internal environment marked by the presence of weakly bound, potentially reactive anon-ligands of strong conjugated acids. The solution will result in a completely new group of Pt (IV) of treatments for cancer therapies with increased toxicity and selective treatment for cancer cells, little toxicity to healthy cells, and high bioavailability from GIT, allowing oral administration. (English) | |||
| Property / summary: The project is subject to new currency, complex, with increased reactivity in an internal environment marked by the presence of weakly bound, potentially reactive anon-ligands of strong conjugated acids. The solution will result in a completely new group of Pt (IV) of treatments for cancer therapies with increased toxicity and selective treatment for cancer cells, little toxicity to healthy cells, and high bioavailability from GIT, allowing oral administration. (English) / rank | |||
Normal rank | |||
Revision as of 16:29, 25 February 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | New means of payment for cancer therapies |
Project in Czech Republic financed by DG Regio |
Statements
5,848,500.0 Czech koruna
0 references
15,596,000.0 Czech koruna
0 references
37.5 percent
0 references
15 June 2016
0 references
28 September 2019
0 references
VUAB Pharma a.s.
0 references
50°9'46.91"N, 14°23'2.26"E
0 references
25263
0 references
Předmětem řešení projektu jsou nové platičité komplexy (Pt(IV)komplexy) se zvýšenou reaktivitou ve vnitrobuněčném prostředí vyznačené tím, že obsahují slabě vázané a potenciálně reaktivní ekvatoriální anion-ligandy bází silných konjugovaných kyselin. Výsledkem řešení bude zcela nová skupina Pt(IV)komplexů pro protinádorovou terapii se zvýšenou toxicitou a selektivitou na nádorové buňky, s malou toxicitou na zdravé buňky a s dobrou biologickou dostupností z GIT, umožňující perorální podání. a. (Czech)
0 references
The project is subject to new currency, complex, with increased reactivity in an internal environment marked by the presence of weakly bound, potentially reactive anon-ligands of strong conjugated acids. The solution will result in a completely new group of Pt (IV) of treatments for cancer therapies with increased toxicity and selective treatment for cancer cells, little toxicity to healthy cells, and high bioavailability from GIT, allowing oral administration. (English)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/15_018/0004605
0 references